A special analysis to determine if ...
A special analysis to determine if a control is right for a clinical trial should not be used in a broader feeling to find out which patients should take which medications, the American Society of Clinical Ontology said. It assessed the technology behind chemotherapy sensitivity and resistance assays (CSRAs), in-vitro laboratory analysis tools to determine whether the tumors of a particular patient would benefit from a particular mark of chemotherapy. The oncology
|